参考文献/References:
[1] Mothe B, Perez I, Domingo P, et al. HIV-1 infection in subjects older than 70: a multicenter cross-sectional assessment in Catalonia, Spain [J]. Curr HIV Res,2009,7(6):597-600.
[2] Ahmed MH, Barakat S, Almobarak AO. Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? [J/OL]. J Obes,2012:483135. doi: 10.1155/2012/483135.
[3] Price JC, Seaberg EC, Latanich R,et al. Risk factors for fatty liver in the Multicenter AIDS Cohort Study [J]. Am J Gastroenterol,2014,109(5):695-704.
[4] Ferré P, Foufelle F. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c [J]. Diabetes Obes Metab, 2010,12(Suppl 2):83-92.
[5] Eissing L, Scherer T, Tödter K,et al. De novo lipogenesis in human fat and liver is linked to ChREBP-β and metabolic health [J]. Nat Commun, 2013,4:1528.
[6] Sherman MP, Schubert U, Williams SA,et al. HIV-1 Vpr displays natural protein-transducing properties: implications for viral pathogenesis [J]. Virology,2002,302(1):95-105.
[7] Cafaro A, Caputo A, Fracasso C,et al. Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine [J]. Nat Med,1999,5(6):643-650.
[8] Sherman KE, Thomas D, Chung RT. Human immunodeficiency virus and liver disease forum 2012 [J]. Hepatology,2014,59(1):307-317.
[9] Tuyama AC, Hong F, Saiman Y,et al. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis [J]. Hepatology,2010,52(2):612-622.
[10] Blackard JT, Hiasa Y, Smeaton L,et al. Compartmentalization of hepatitis C virus (HCV) during HCV/HIV coinfection [J]. J Infect Dis, 2007,195(12):1765-1773.
[11] Sterling RK, Chiu S, Snider K,et al. The prevalence and risk factors for abnormal liver enzymes in HIV-positive patients without hepatitis B or C coinfections [J]. Dig Dis Sci,2008,53(5):1375-1382.
[12] Guaraldi G, Squillace N, Stentarelli C,et al. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors [J]. Clin Infect Dis,2008,47(2):250-257.
[13] Zhou F, Xue M, Qin D,et al. HIV-1 Tat promotes Kaposi’s sarcoma-associated herpesvirus (KSHV) vIL-6-induced angiogenesis and tumorigenesis by regulating PI3K/PTEN/AKT/GSK-3β signaling pathway [J/OL]. PLoS One, 2013,8(1):e53145. doi: 10.1371/journal.pone.0053145.
[14] Yao S, Hu M, Hao T,et al. MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-κB signaling [J]. Nucleic Acids Res,2015,43(19):9362-9378.
[15] Nookala AR, Shah A, Noel RJ,et al. HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways [J/OL]. PLoS One, 2013,8(11):e78855. doi: 10.1371/journal.pone.0078855.
[16]Li L, He ML, Wang K, et al.Buffering agent via insulin-mediated activation of PI3K/AKT signaling pathway to regulate lipid metabolism in lactating goats[J].Physiol Res,2018. [Epub ahead of print]
[17] Zhang M, Chi X, Qu N,et al. Long noncoding RNA lncARSR promotes hepatic lipogenesis via Akt/SREBP-1c pathway and contributes to the pathogenesis of nonalcoholic steatohepatitis [J]. Biochem Biophys Res Commun,2018,499(1):66-70.